Genomic landscape of gastric cancer: molecular classification and potential targets

Gastric cancer imposes a considerable health burden worldwide, and its mortality ranks as the second highest for all types of cancers. The limited knowledge of the molecular mechanisms underlying gastric cancer tumorigenesis hinders the development of therapeutic strategies. However, ongoing collabo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science China. Life sciences 2017-02, Vol.60 (2), p.126-137
Hauptverfasser: Guo, Jiawei, Yu, Weiwei, Su, Hui, Pang, Xiufeng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 137
container_issue 2
container_start_page 126
container_title Science China. Life sciences
container_volume 60
creator Guo, Jiawei
Yu, Weiwei
Su, Hui
Pang, Xiufeng
description Gastric cancer imposes a considerable health burden worldwide, and its mortality ranks as the second highest for all types of cancers. The limited knowledge of the molecular mechanisms underlying gastric cancer tumorigenesis hinders the development of therapeutic strategies. However, ongoing collaborative sequencing efforts facilitate molecular classification and unveil the genomic landscape of gastric cancer. Several new drivers and tumorigenic pathways in gastric cancer, including chromatin remodeling genes, RhoA-related pathways, TP53 dysregulation, activation of receptor tyrosine kinases, stem cell pathways and abnormal DNA methylation, have been revealed. These newly identified genomic alterations await translation into clinical di- agnosis and targeted therapies. Considering that loss-of-function mutations are intractable, synthetic lethality could be em- ployed when discussing feasible therapeutic strategies. Although many challenges remain to be tackled, we are optimistic re- garding improvements in the prognosis and treatment of gastric cancer in the near future.
doi_str_mv 10.1007/s11427-016-0034-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1881756409</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>671420124</cqvip_id><sourcerecordid>4319893421</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-bf6f372e662378d109ba2d2c25292a1b7eab95a99bbcddd0372cb3f24b9bcd443</originalsourceid><addsrcrecordid>eNqNkT1OxDAQhS0EAgQcgAZF0NAExj-x1yVC_ElINFBbtuMsQUm82EnBVTgLd-IKDNoFIQqEG1vj773x-BGyT-GEAqjTTKlgqgQqSwAuSrpGtulM6pLOZnodz1KJUnGotshezk-Ai3NgSm2SLaaEBKr5Nnm4CkPsW190dqizt4tQxKaY2zwmLHo7-JDe316LPnbBT51Nhe9szm3Teju2cShQViziGIaxtV0x2jQPY94lG43tcthb7Tvk4fLi_vy6vL27ujk_uy29UNVYukY2XLEgJeNqVlPQzrKaeVYxzSx1KlinK6u1c76ua0DWO94w4TQWhOA75Hjpu0jxeQp5NH2bfehwmBCnbPArqKqkAP0PlEnFmRAM0aNf6FOc0oCDIIV2GrQEpOiS8inmnEJjFqntbXoxFMxnQmaZkMGEzGdChqLmYOU8uT7U34qvPBBgSyDj1TAP6UfrP1wPVy95jMP8GXXfxlIhDJQJ_gE6zqdp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1875690960</pqid></control><display><type>article</type><title>Genomic landscape of gastric cancer: molecular classification and potential targets</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>SpringerLink Journals - AutoHoldings</source><creator>Guo, Jiawei ; Yu, Weiwei ; Su, Hui ; Pang, Xiufeng</creator><creatorcontrib>Guo, Jiawei ; Yu, Weiwei ; Su, Hui ; Pang, Xiufeng</creatorcontrib><description>Gastric cancer imposes a considerable health burden worldwide, and its mortality ranks as the second highest for all types of cancers. The limited knowledge of the molecular mechanisms underlying gastric cancer tumorigenesis hinders the development of therapeutic strategies. However, ongoing collaborative sequencing efforts facilitate molecular classification and unveil the genomic landscape of gastric cancer. Several new drivers and tumorigenic pathways in gastric cancer, including chromatin remodeling genes, RhoA-related pathways, TP53 dysregulation, activation of receptor tyrosine kinases, stem cell pathways and abnormal DNA methylation, have been revealed. These newly identified genomic alterations await translation into clinical di- agnosis and targeted therapies. Considering that loss-of-function mutations are intractable, synthetic lethality could be em- ployed when discussing feasible therapeutic strategies. Although many challenges remain to be tackled, we are optimistic re- garding improvements in the prognosis and treatment of gastric cancer in the near future.</description><identifier>ISSN: 1674-7305</identifier><identifier>EISSN: 1869-1889</identifier><identifier>DOI: 10.1007/s11427-016-0034-1</identifier><identifier>PMID: 27460193</identifier><language>eng</language><publisher>Beijing: Science China Press</publisher><subject>Biomedical and Life Sciences ; Chromatin Assembly and Disassembly ; DNA Methylation ; DNA甲基化 ; Gene Expression Regulation, Neoplastic ; Genomics - methods ; Humans ; Life Sciences ; Mutation ; Receptor Protein-Tyrosine Kinases - genetics ; Review ; rhoA GTP-Binding Protein - genetics ; Stem Cells - cytology ; Stomach Neoplasms - genetics ; Tumor Suppressor Protein p53 - genetics ; 临床诊断 ; 分子分类 ; 受体酪氨酸激酶 ; 基因组图谱 ; 胃癌 ; 靶向治疗 ; 靶点</subject><ispartof>Science China. Life sciences, 2017-02, Vol.60 (2), p.126-137</ispartof><rights>The Author(s) 2016</rights><rights>Science China Life Sciences is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-bf6f372e662378d109ba2d2c25292a1b7eab95a99bbcddd0372cb3f24b9bcd443</citedby><cites>FETCH-LOGICAL-c475t-bf6f372e662378d109ba2d2c25292a1b7eab95a99bbcddd0372cb3f24b9bcd443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/60112X/60112X.jpg</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11427-016-0034-1$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11427-016-0034-1$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>313,314,780,784,792,27921,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27460193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guo, Jiawei</creatorcontrib><creatorcontrib>Yu, Weiwei</creatorcontrib><creatorcontrib>Su, Hui</creatorcontrib><creatorcontrib>Pang, Xiufeng</creatorcontrib><title>Genomic landscape of gastric cancer: molecular classification and potential targets</title><title>Science China. Life sciences</title><addtitle>Sci. China Life Sci</addtitle><addtitle>Sci China Life Sci</addtitle><description>Gastric cancer imposes a considerable health burden worldwide, and its mortality ranks as the second highest for all types of cancers. The limited knowledge of the molecular mechanisms underlying gastric cancer tumorigenesis hinders the development of therapeutic strategies. However, ongoing collaborative sequencing efforts facilitate molecular classification and unveil the genomic landscape of gastric cancer. Several new drivers and tumorigenic pathways in gastric cancer, including chromatin remodeling genes, RhoA-related pathways, TP53 dysregulation, activation of receptor tyrosine kinases, stem cell pathways and abnormal DNA methylation, have been revealed. These newly identified genomic alterations await translation into clinical di- agnosis and targeted therapies. Considering that loss-of-function mutations are intractable, synthetic lethality could be em- ployed when discussing feasible therapeutic strategies. Although many challenges remain to be tackled, we are optimistic re- garding improvements in the prognosis and treatment of gastric cancer in the near future.</description><subject>Biomedical and Life Sciences</subject><subject>Chromatin Assembly and Disassembly</subject><subject>DNA Methylation</subject><subject>DNA甲基化</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genomics - methods</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Mutation</subject><subject>Receptor Protein-Tyrosine Kinases - genetics</subject><subject>Review</subject><subject>rhoA GTP-Binding Protein - genetics</subject><subject>Stem Cells - cytology</subject><subject>Stomach Neoplasms - genetics</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><subject>临床诊断</subject><subject>分子分类</subject><subject>受体酪氨酸激酶</subject><subject>基因组图谱</subject><subject>胃癌</subject><subject>靶向治疗</subject><subject>靶点</subject><issn>1674-7305</issn><issn>1869-1889</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkT1OxDAQhS0EAgQcgAZF0NAExj-x1yVC_ElINFBbtuMsQUm82EnBVTgLd-IKDNoFIQqEG1vj773x-BGyT-GEAqjTTKlgqgQqSwAuSrpGtulM6pLOZnodz1KJUnGotshezk-Ai3NgSm2SLaaEBKr5Nnm4CkPsW190dqizt4tQxKaY2zwmLHo7-JDe316LPnbBT51Nhe9szm3Teju2cShQViziGIaxtV0x2jQPY94lG43tcthb7Tvk4fLi_vy6vL27ujk_uy29UNVYukY2XLEgJeNqVlPQzrKaeVYxzSx1KlinK6u1c76ua0DWO94w4TQWhOA75Hjpu0jxeQp5NH2bfehwmBCnbPArqKqkAP0PlEnFmRAM0aNf6FOc0oCDIIV2GrQEpOiS8inmnEJjFqntbXoxFMxnQmaZkMGEzGdChqLmYOU8uT7U34qvPBBgSyDj1TAP6UfrP1wPVy95jMP8GXXfxlIhDJQJ_gE6zqdp</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Guo, Jiawei</creator><creator>Yu, Weiwei</creator><creator>Su, Hui</creator><creator>Pang, Xiufeng</creator><general>Science China Press</general><general>Springer Nature B.V</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>~WA</scope><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20170201</creationdate><title>Genomic landscape of gastric cancer: molecular classification and potential targets</title><author>Guo, Jiawei ; Yu, Weiwei ; Su, Hui ; Pang, Xiufeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-bf6f372e662378d109ba2d2c25292a1b7eab95a99bbcddd0372cb3f24b9bcd443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biomedical and Life Sciences</topic><topic>Chromatin Assembly and Disassembly</topic><topic>DNA Methylation</topic><topic>DNA甲基化</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genomics - methods</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Mutation</topic><topic>Receptor Protein-Tyrosine Kinases - genetics</topic><topic>Review</topic><topic>rhoA GTP-Binding Protein - genetics</topic><topic>Stem Cells - cytology</topic><topic>Stomach Neoplasms - genetics</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><topic>临床诊断</topic><topic>分子分类</topic><topic>受体酪氨酸激酶</topic><topic>基因组图谱</topic><topic>胃癌</topic><topic>靶向治疗</topic><topic>靶点</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guo, Jiawei</creatorcontrib><creatorcontrib>Yu, Weiwei</creatorcontrib><creatorcontrib>Su, Hui</creatorcontrib><creatorcontrib>Pang, Xiufeng</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Springer Nature OA/Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Science China. Life sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guo, Jiawei</au><au>Yu, Weiwei</au><au>Su, Hui</au><au>Pang, Xiufeng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genomic landscape of gastric cancer: molecular classification and potential targets</atitle><jtitle>Science China. Life sciences</jtitle><stitle>Sci. China Life Sci</stitle><addtitle>Sci China Life Sci</addtitle><date>2017-02-01</date><risdate>2017</risdate><volume>60</volume><issue>2</issue><spage>126</spage><epage>137</epage><pages>126-137</pages><issn>1674-7305</issn><eissn>1869-1889</eissn><abstract>Gastric cancer imposes a considerable health burden worldwide, and its mortality ranks as the second highest for all types of cancers. The limited knowledge of the molecular mechanisms underlying gastric cancer tumorigenesis hinders the development of therapeutic strategies. However, ongoing collaborative sequencing efforts facilitate molecular classification and unveil the genomic landscape of gastric cancer. Several new drivers and tumorigenic pathways in gastric cancer, including chromatin remodeling genes, RhoA-related pathways, TP53 dysregulation, activation of receptor tyrosine kinases, stem cell pathways and abnormal DNA methylation, have been revealed. These newly identified genomic alterations await translation into clinical di- agnosis and targeted therapies. Considering that loss-of-function mutations are intractable, synthetic lethality could be em- ployed when discussing feasible therapeutic strategies. Although many challenges remain to be tackled, we are optimistic re- garding improvements in the prognosis and treatment of gastric cancer in the near future.</abstract><cop>Beijing</cop><pub>Science China Press</pub><pmid>27460193</pmid><doi>10.1007/s11427-016-0034-1</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1674-7305
ispartof Science China. Life sciences, 2017-02, Vol.60 (2), p.126-137
issn 1674-7305
1869-1889
language eng
recordid cdi_proquest_miscellaneous_1881756409
source MEDLINE; Alma/SFX Local Collection; SpringerLink Journals - AutoHoldings
subjects Biomedical and Life Sciences
Chromatin Assembly and Disassembly
DNA Methylation
DNA甲基化
Gene Expression Regulation, Neoplastic
Genomics - methods
Humans
Life Sciences
Mutation
Receptor Protein-Tyrosine Kinases - genetics
Review
rhoA GTP-Binding Protein - genetics
Stem Cells - cytology
Stomach Neoplasms - genetics
Tumor Suppressor Protein p53 - genetics
临床诊断
分子分类
受体酪氨酸激酶
基因组图谱
胃癌
靶向治疗
靶点
title Genomic landscape of gastric cancer: molecular classification and potential targets
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T12%3A01%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genomic%20landscape%20of%20gastric%20cancer%EF%BC%9A%20molecular%20classification%20and%20potential%20targets&rft.jtitle=Science%20China.%20Life%20sciences&rft.au=Guo,%20Jiawei&rft.date=2017-02-01&rft.volume=60&rft.issue=2&rft.spage=126&rft.epage=137&rft.pages=126-137&rft.issn=1674-7305&rft.eissn=1869-1889&rft_id=info:doi/10.1007/s11427-016-0034-1&rft_dat=%3Cproquest_cross%3E4319893421%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1875690960&rft_id=info:pmid/27460193&rft_cqvip_id=671420124&rfr_iscdi=true